NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
1.820
-0.060 (-3.19%)
At close: Feb 11, 2026, 4:00 PM EST
1.800
-0.020 (-1.10%)
After-hours: Feb 11, 2026, 7:00 PM EST
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $53.88 million as of February 11, 2026. Its market cap has increased by 56.18% in one year.
Market Cap
53.88M
Enterprise Value
58.73M
1-Year Change
56.18%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has decreased from $65.80M to $53.88M, a decrease of -18.11%. That is a compound annual growth rate of -2.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 52.80M | -30.62% |
| Dec 31, 2025 | 76.10M | 186.09% |
| Dec 31, 2024 | 26.60M | -31.09% |
| Dec 29, 2023 | 38.60M | -48.60% |
| Dec 30, 2022 | 75.10M | -73.28% |
| Dec 31, 2021 | 281.10M | 328.51% |
| Dec 31, 2020 | 65.60M | 2.02% |
| Dec 31, 2019 | 64.30M | -30.26% |
| Dec 31, 2018 | 92.20M | 44.97% |
| Dec 29, 2017 | 63.60M | -3.34% |
| Nov 20, 2017 | 65.80M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InflaRx | 57.14M |
| Metagenomi Therapeutics | 56.32M |
| Kazia Therapeutics | 55.90M |
| Radiopharm Theranostics | 55.50M |
| Grace Therapeutics | 55.40M |
| TScan Therapeutics | 54.79M |
| Nutriband | 53.06M |
| Instil Bio | 52.29M |